Targeting cancer stem cells in squamous cell carcinoma

Head and neck squamous cell carcinoma (HNSCC) is a highly aggressive tumor and the sixth most common cancer worldwide. Current treatment strategies for HNSCC are surgery, radiotherapy, chemotherapy, immunotherapy or combinatorial therapies. However, the overall 5-year survival rate of HNSCC patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Demeng, Wang, Cun-Yu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6770277/
https://www.ncbi.nlm.nih.gov/pubmed/31598386
http://dx.doi.org/10.1093/pcmedi/pbz016

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6770277/
https://www.ncbi.nlm.nih.gov/pubmed/31598386
http://dx.doi.org/10.1093/pcmedi/pbz016

Ejemplares similares